4th Quarter - Report
MCDERMOTT+ LLC for 340B HEALTH
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to the 340B drug pricing program. H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL STAUFFER | 2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John Tierney |
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
| EMMA ZIMMERMAN | — |
Health Issues HCR
Issues relating to the 340B drug pricing program. H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL STAUFFER | 2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John Tierney |
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
| EMMA ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.